News FDA reviewers slam PTC's Duchenne drug ahead of meeting FDA staff not persuaded by patchy clinical trial evidence for Translarna.
News Bungled Brexit move would trigger public health crisis, warn... Regulator could be crippled by staff exodus during relocation.
News Public trusts supermarkets more than pharma - poll Swiss company looks move on from Tamiflu scandal
Brexit Pharma and biotech warn of Brexit threat to science recruitm... Government must strike science R&D deal with EU, says ABPI
Events Partner Content Clinical Trial Supply Midwest 2017 Leading clinical trial supply event in Chicago
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
